mesothelioma cancer survival rate
Approximately 55 percent of mesothelioma patients live longer than 6 months, while roughly 35 percent live longer than one year. Only 9 percent of people diagnosed with mesothelioma survive longer than 5 years.

This question is commonly asked by those who have been diagnosed with mesothelioma, a fatal form of cancer caused by asbestos. Unfortunately, as with most diseases, there is no one answer to how long a mesothelioma patient will live.
1 year after diagnosis 33%
5 years after diagnosis 9%
According to the study, peritoneal mesothelioma survivorship has especially shown significant improvement, largely due to new forms of treatment, such as hyperthermic intraperitoneal chemotherapy (HIPEC).

“How Long Can You Live With Mesothelioma?”
This question is commonly asked by those who have been diagnosed with mesothelioma, a fatal form of cancer caused by asbestos. Unfortunately, as with most diseases, there is no one answer to how long a mesothelioma patient will live.Mesothelioma Survival Rates
6 months after diagnosis 55%1 year after diagnosis 33%
5 years after diagnosis 9%
Survival Rates for Mesothelioma Are Improving
The good news is that survival rates for mesothelioma patients are improving. A 2015 meta-study looked at 20 years worth of results from 1992 – 2012, and during that period the two major forms of mesothelioma (pleural and peritoneal) have both seen an improvement in survivorship.Mesothelioma Survival Rate by Type
years | Pleural | Peritoneal | Pericardial |
1 year | 73% | 92% | 51% |
3 years | 23% | 74% | 26% |
5 years | 12% | 65% | 23% |
10 years | 4.7% | 39% | (N/A) |
According to the study, peritoneal mesothelioma survivorship has especially shown significant improvement, largely due to new forms of treatment, such as hyperthermic intraperitoneal chemotherapy (HIPEC).